The Dementia Diagnosis App segmentation by application delineates four primary use‑cases: clinical assessment, home‑based monitoring, research support, and telehealth integration. Clinical assessment apps are deployed within hospitals and memory clinics to augment neuropsychological testing, contributing roughly 40 % of market revenue due to high adoption rates among neurologists and the premium pricing of validated diagnostic tools. Home‑based monitoring solutions, which enable caregivers to track cognitive decline through daily tasks and passive sensor data, account for about 35 % of the market, reflecting the growing demand for decentralized care models. Research support platforms, designed for longitudinal data collection in clinical trials, represent 15 % of the market, driven by pharmaceutical investment in early‑stage therapeutic development. Finally, telehealth integration apps, which embed diagnostic algorithms within virtual consultation workflows, hold a 10 % share, as they facilitate remote specialist access while maintaining compliance with health‑data regulations. Together, these application segments shape the overall market size by aligning product value propositions with distinct stakeholder needs.